Niwat Lukkanawong

Charoenkrung Pracharak Hospital

Papers

1

Total Citations

7

H-Index

1

About

Dr. Niwat Lukkanawong is a distinguished urological surgeon whose research centers on minimally invasive treatments for ureteropelvic junction obstruction (UPJO), a condition where the kidney meets the ureter. His most cited work, a 2022 comparative study, rigorously evaluated the outcomes of laparoscopic pyeloplasty versus robot-assisted laparoscopic pyeloplasty, drawing on over a decade of clinical data from March 2008 to May 2019. This investigation, which has garnered 7 citations, provides critical insights into the efficacy and safety of these advanced surgical techniques, helping to guide clinical decision-making in urology. Dr. Lukkanawong’s contributions are particularly notable for their focus on retroperitoneal approaches, a specialized method that reduces recovery time and complications. By systematically comparing these two robotic and laparoscopic modalities, he has advanced the evidence base for personalized surgical care in UPJO patients. His work underscores a commitment to improving patient outcomes through rigorous, data-driven research, making him a key figure in the evolution of minimally invasive urological surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
A Comparison Between Laparoscopic and Robot-Assisted Laparoscopic Pyeloplasty in Patients with Ureteropelvic Junction Obstruction
7 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Charoenkrung Pracharak Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 22 days ago